Relmada Therapeutics Stock Forecast - Relative Strength Index
| RLMD Stock | USD 3.02 0.12 4.14% |
Relmada Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Relmada Therapeutics stock prices and determine the direction of Relmada Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Relmada Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Relmada |
Open Interest Against 2024-12-20 Relmada Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Relmada Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Relmada Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Relmada Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Relmada Therapeutics' open interest, investors have to compare it to Relmada Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Relmada Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Relmada. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 35.62 | 35.62 |
| Check Relmada Therapeutics Volatility | Backtest Relmada Therapeutics | Information Ratio |
Relmada Therapeutics Trading Date Momentum
| On December 01 2024 Relmada Therapeutics was traded for 3.02 at the closing time. The top price for the day was 3.07 and the lowest listed price was 2.78 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 did not cause price change. The trading delta at closing time against the current closing price is 4.30% . |
| Compare Relmada Therapeutics to competition |
Other Forecasting Options for Relmada Therapeutics
For every potential investor in Relmada, whether a beginner or expert, Relmada Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Relmada Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Relmada. Basic forecasting techniques help filter out the noise by identifying Relmada Therapeutics' price trends.View Relmada Therapeutics Related Equities
| Risk & Return | Correlation |
Relmada Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Relmada Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Relmada Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Relmada Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Relmada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relmada Therapeutics shares will generate the highest return on investment. By undertsting and applying Relmada Therapeutics stock market strength indicators, traders can identify Relmada Therapeutics entry and exit signals to maximize returns.
Relmada Therapeutics Risk Indicators
The analysis of Relmada Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Relmada Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting relmada stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.73 | |||
| Semi Deviation | 2.64 | |||
| Standard Deviation | 4.02 | |||
| Variance | 16.15 | |||
| Downside Variance | 8.39 | |||
| Semi Variance | 6.98 | |||
| Expected Short fall | (3.21) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Relmada Therapeutics is a strong investment it is important to analyze Relmada Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Relmada Therapeutics' future performance. For an informed investment choice regarding Relmada Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Relmada Therapeutics. If investors know Relmada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Relmada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Return On Assets (0.59) | Return On Equity (1.00) |
The market value of Relmada Therapeutics is measured differently than its book value, which is the value of Relmada that is recorded on the company's balance sheet. Investors also form their own opinion of Relmada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Relmada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Relmada Therapeutics' market value can be influenced by many factors that don't directly affect Relmada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Relmada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relmada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.